Sun, Wockhardt recall drugs from US market

Sun, Wockhardt recall drugs from US market

Sun, Wockhardt recall drugs from US market
Pharma sector majors Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle, from the US market for “failed dissolution specification”, while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg from the same market for “CGMP violations”.

In a separate notification, the US FDA said that Wockhardt also initiated voluntary recall of 1,704 and 3,378 bottles of its Lisinopril Tablets USP, 5 mg and 20 mg respectively (both 1000-count ) bottles from the USA market.